Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AST-301 |
Trade Name | |
Synonyms | AST301|AST 301|EP301|EP-301|EP 301 |
Drug Descriptions |
AST-301 is a DNA vaccine that encodes the ERBB2 (HER2) intracellular domain, with potential antitumor activity (Journal for ImmunoTherapy of Cancer 2021;9, Abstract 776). |
DrugClasses | HER2 (ERBB2) Vaccine 14 |
CAS Registry Number | NA |
NCIT ID | C190734 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AST-301 | AST-301 | 0 | 0 |
AST-301 + Capecitabine + Pembrolizumab + Sargramostim | AST-301 Capecitabine Pembrolizumab Sargramostim | 0 | 1 |
AST-301 + Trastuzumab | AST-301 Trastuzumab | 0 | 0 |